Olivier Geneste
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 4
- Physiology top 2%
- Epidemiology top 5%
- Autophagy in Disease and Therapy 3
- Molecular Biology top 5%
- Cell death mechanisms and regulation 11
- Cancer therapeutics and mechanisms 4
- Glutathione Transferases and Polymorphisms 2
- Cell Biology top 5%
-
- Cancer-related Molecular Pathways 4
-
- Pharmacogenetics and Drug Metabolism 3
-
- Cancer Mechanisms and Therapy 2
Olivier Geneste
34 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 435
- Physiology 125
- Epidemiology 894
- Molecular Biology 1.7k
- Cell Biology 372
Countries citing papers authored by Olivier Geneste
This map shows the geographic impact of Olivier Geneste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Geneste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Geneste more than expected).
Fields of papers citing papers by Olivier Geneste
This network shows the impact of papers produced by Olivier Geneste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Geneste. The network helps show where Olivier Geneste may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Olivier Geneste, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 36 | |
| 2 | 2013 | 177 | |
| 3 | Bax activation by engagement with, then release from, the BH3 binding site of Bcl-xL. | 2011 | 2 |
| 4 | 2010 | 30 | |
| 5 | Functional and physical interaction between Bcl‐XL and a BH3‐like domain in Beclin‐1breakdown → | 2007 | 912 |
| 6 | 2007 | 101 | |
| 7 | 2006 | 21 | |
| 8 | 2006 | 113 | |
| 9 | 2005 | 6 | |
| 10 | 2003 | 53 | |
| 11 | 1999 | 48 | |
| 12 | 1998 | 83 | |
| 13 | 1998 | 202 | |
| 14 | 1997 | 17 | |
| 15 | 1997 | 85 | |
| 16 | 1995 | 41 | |
| 17 | 1993 | 13 | |
| 18 | 1993 | 134 | |
| 19 | 1991 | 76 | |
| 20 | 1991 | 35 |
About Olivier Geneste
Olivier Geneste is a scholar working on Molecular Biology, Pharmacology and Cancer Research, having authored 35 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (11 papers), Carcinogens and Genotoxicity Assessment (4 papers), Cancer therapeutics and mechanisms (4 papers), Cancer-related Molecular Pathways (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Autophagy in Disease and Therapy (3 papers), Cancer Mechanisms and Therapy (2 papers) and Glutathione Transferases and Polymorphisms (2 papers). The work is most often cited by research in Cancer Research (435 citations), Physiology (125 citations) and Epidemiology (894 citations). Olivier Geneste has collaborated with scholars based in France, United Kingdom and Italy. Frequent co-authors include Philippe Juin, Richard Treisman, Fabien Gautier, John A. Hickman, Guido Kroemer, Alfredo Criollo, Ezgi Tasdemir, Maria Chiara Maiuri, Jean‐Christophe Rain and Gérard Pierron. Their work appears in journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.